To clarify where and how ␤-amyloid begins to deposit in senile plaques, we examined the ultrastructural localization of amyloid ␤ protein (A␤) in diffuse plaques of brains with hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease (AD), and from nondemented aged subjects. Serial ultrathin sections of osmium-plastic blocks were immunogold-labeled for A␤x-42 (A␤42), and sections on grids were observed under the electron microscope (EM) after observing the exact localization of the diffuse plaques in sections on glass slides by the reflection contrast microscope. A␤42 deposition, which was decollated with gold particles, appeared in 3 forms in all subjects under the EM: 1) Scattered small bundles of amyloid fibrils between cell processes, frequently seen in the densely stained area of diffuse plaques. 2) Scattered small foci of nonfibrillar materials between cell processes as a relatively minor form. 3) A␤42 on a part of the cell surface plasma membrane of normal appearing cell processes, a major form in weakly immunostained areas. The last form was not associated with degenerative neurites or reactive glia. A␤42 deposition on the cell surface plasma membrane appears to be an initial event in diffuse plaques, and then it develops into amorphous/fibrillar amyloid between cell processes.
INTRODUCTION
Cerebral ␤ amyloid is a polymer of the amyloid ␤ protein (A␤), and is a hydrophobic, self-aggregating peptide consisting of 40-42 residues (1). A␤ is derived from a larger membrane-bound protein, the amyloid ␤ protein precursor (A␤PP) (2) . Analyses in patients with earlyonset familial Alzheimer disease (AD) revealed point mutations in the A␤PP gene near the A␤ cleavage sites, and the brains of the subjects with these mutations showed typical AD pathology, both numerous neurofibrillary tangles and senile plaques (3, 4) . Presenilin 1 is a causative gene in early-onset familial AD. Mutations in the presenilin-1 gene result in an increased production of A␤x-42 (A␤42) compared with A␤x-40 (A␤40) (5) , and enhanced A␤ deposition in A␤PP/presenilin double transgenic mice (6) . These findings support the idea that A␤ plays a key role in the pathogenesis of AD, and therefore, it is quite important to know how A␤ starts to deposit in senile plaques.
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of the A␤PP gene at codon 693, the 22nd amino acid of A␤ (Glu to Gln substitution) (7) , and is characterized by severe amyloid angiopathy and parenchymal diffuse plaques (8) . HCHWA-D shows age-dependent plaque pathology: fine diffuse plaques and cloud-like diffuse cortical labeling in middle-ages patients, and dense diffuse plaques and coarse and homogeneous plaques in older patients (9) . In middle-aged subjects, diffuse plaques lack glial reaction and neuritic changes, and may therefore represent a relatively early stage of ␤-amyloid deposition (9) . Moreover, the density of diffuse plaques in HCHWA-D brains is sufficiently high for electron microscopic (EM) studies, where only a small field of 1 mm 2 can be observed. Tissue samples from middle-aged subjects with HCHWA-D are suitable for our examination of initial A␤ deposition.
Diffuse plaques were consistently immunoreactive for A␤42, but most of them were negative or faintly positive for A␤40 in HCHWA-D (9, 10), AD and nondemented subjects (11) (12) (13) . Therefore, A␤42, but not A␤40, can be a ''seed'' of A␤ deposition (14) . In this study, we first found A␤42 on the plasma membrane as a novel form of A␤ deposition in HCHWA-D brains, and confirmed the findings in the cerebellar molecular layer of AD, where diffuse plaque formation progresses in the late stage of the disease (15) , and also in frontal cortex of nondemented elderly subjects. We discuss the possibility that A␤ starts to deposit as a membrane-bound form on cell surface plasma membrane.
MATERIALS AND METHODS
We examined autopsied brains from 3 HCHWA-D patients, aged 47, 50, and 64 yr; 2 AD patients, aged 78 and 81; and 3 
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Asterisks showed the same nucleus in the adjacent sections, and arrows indicate bright reflection (artifact) from dusts attached during the immunostaining. The varying color of the RCM sections (b-h) depends on the intensity of toluidine blue counterstaining, which becomes yellow under RCM, and also on filter setting and the film type used. b-h: MBC42, silver enhancement, epoxy resin, 100-nm-thick; ϫ720.
nondemented subjects, aged 72, 78, and 81. Small pieces of the frontal association cortex from all subjects and the cerebellar cortex from AD patients were fixed in 1% formaldehyde ϩ 1.5% glutaraldehyde (HCHWA-D) or 4% formaldehyde ϩ 1% glutaraldehyde (AD and nondemented) solution, osmified, and embedded in Spurr or Epon for conventional EM. To select appropriate areas for immuno-EM studies, we first cut semithin (0.5 m) sections of several blocks from each subject, and immunostained them for A␤ using an ABC elite kit (Vector, Burlingame, CA) and diaminobenzidine developer. After removing resin with KOH-ethanol and pretreating with formic acid, as previously described (16) , semithin sections were incubated with A␤42 end-specific monoclonal antibody, MBC42, which selectively recognizes the free C-terminal 42 end of A␤, but does not recognize the 40 or 43 end or A␤PP (17) . Then, we selected the suitable areas having diffuse plaques (Fig. 1a) , and examined them by a combination of reflection contrast microscope (RCM; Leica DMR, Germany) (18, 19) and EM as follows. We cut serial ultrathin (100 nm) sections, placed them alternatively on glass slides for RCM and Ni grids for EM, and then immunolabeled with MBC42. Some RCM sections on glass slides were also labeled with A␤ C-terminal 40 end-specific antibody, MBC40. First, paired thin sections on glass slide for RCM and on grid for EM were etched with 10% H 2 O 2 for 5 min, then treated with 1% periodic acid solution for 10 min. Next, they were incubated with MBC42 (culture supernatant at 1:5 to 1:40 dilution or purified IgG at 0.05 g/ml in 2% BSA-PBS) overnight at room temperature after blocking with 5% normal goat serum. They were then incubated with gold-tagged goat anti-mouse IgG (Fc) at 1:10 dilution in 2% BSA-PBS for 2 h. We used 10-nm gold (Amersham; RPN 425) for EM sections on grids, and 5-nm gold (RPN 424) for RCM sections on glass slides. After fixation with 1% glutaraldehyde in 0.1 M phosphate buffer for 5 min, the EM sections on grids were stained with conventional uranyl acetate and lead citrate, and the RCM sections on glass slides were treated with Danscher's silver enhancing solution for 20 min in the dark (20) , then briefly counterstained with 0.1% toluidine blue. The exact site and size of the diffuse plaques were clearly seen in RCM sections, and we observed the same area with quite similar morphology in the adjacent EM sections. We examined 2 to 22 diffuse plaques in each EM block. We compared the plaque density between RCM sections and corresponding paraffin sections taken from the same area, and confirmed that all diffuse plaques were successfully labeled without formic acid on plastic sections. For controls, sections were stained with normal mouse IgG at the same concentration, or with MBC42 preabsorbed with A␤1-42 synthetic peptide (20 g/ml, Backem California).
RESULTS
The combination of MBC42 and RCM demonstrated all diffuse plaques in the ultrathin (100-nm-thick) sections on glass. Sensitivity of this method is quite similar to that of paraffin sections with formic acid pretreatment. The RCM showed distinctive staining of frontal diffuse plaques in HCHWA-D ( Fig. 1 b, d ), AD (Fig. 1e) , and nondemented ( Fig. 1f) on ultrathin sections without formic acid pretreatment, whereas bright field microscopy with the conventional peroxidase-diaminobenzidine method showed faint labeling of diffuse plaques due to the thickness (0.5 m) even after removing resin and formic acid pretreatment (Fig. 1a) . Cerebellar diffuse plaques in AD were consistently positive with MBC42 (Fig. 1g ), but negative with MBC40 (Fig. 1h) . In the control study, senile plaques disappeared with preabsorption of the antibody (Fig. 1c) . The RCM observation provided exact location, size, intensity and pattern of immunolabeling, and the relation to anatomical structures of plaques. Using this information as a guide, we observed the adjacent sections on EM grids, and found 3 major forms of immunogold labeling with MBC42 in the area of frontal diffuse plaques of HCHWA-D (Fig. 2) , AD (Fig. 3) , and nondemented aged (Fig. 4) , and in cerebellar diffuse plaques of AD (Fig. 5 ). Findings were summarized in the Table.
Frontal Diffuse Plaques
Fibrillar Form: This form was dominant in areas with intense immunolabeling under RCM (Fig. 1d, arrows) . Such areas were often positive for MBC40. Small bundles of apparent amyloid fibrils, 7-8-nm in diameter, appeared extracellularly between cell processes (Figs. 2a, b, 3e, 4b). The plasma membrane around amyloid fibrils tended to be obscure (Fig. 2a) . Some of the bundles were associated with small degenerative neurites containing dense membranous bodies in the eldest HCHWA-D subject (64 Y) and in AD (78, 81 Y).
Nonfibrillar Form: A␤42-positive electron-dense materials appeared between cell processes without an apparent fibrillar structure, or as a mixture of amorphous and delicate fibrillar materials (Figs. 2b, 4b ). This form was minor in diffuse plaques and seemed to be intermediate between membrane-bound and fibrillar forms.
Membrane-bound Form: This form was predominant in all subjects (Figs. 2-4) . A part of the cell surface plasma membrane showed gold labeling in diffuse plaques without any other morphological changes (Figs. 2-4) . Small numbers of gold particles appeared on both inside and outside of the plasma membrane. Both plasma membranes of the contacting cell processes became positive, and there were no materials between gold-bearing plasma (Fig. 1d) . The plasma membrane around amyloid fibrils has disappeared (large arrows). b: Area with a mixture of amorphous and delicate fibrillar materials (large arrow) and labeling on a part of the axonal (presynaptic) plasma membrane (arrowhead). c: Labeling of the plasma membrane of an axon terminal. d: Plasma membrane-form of A␤ in a weakly stained area. e: Area with plasma membrane labeling in the youngest subject. a-e: Synaptic clefts (small arrows) were consistently free of gold labeling; MBC42, 10-nm gold, ϫ27,000. membranes. The areas with the membrane-bound form of A␤42 were associated with neither degenerating neurites nor glial reaction, and scattered in plaque areas of weak immunolabeling under RCM (Figs. 1b, e, f, 3a) . Such areas were consistently MBC40-negative. They appeared regardless of plaque size or part, i.e. both in the center and the periphery of the plaque. Some appeared on the plasma membrane of axon terminals (Figs. 2b, c, 3f ), while few were on astrocytic processes (Fig. 3c) , but most were of unknown origin (Figs. 2, 3) . Synaptic clefts were never labeled with gold (Figs. 2, 3, 4, small arrows) . Small MBC42-positive areas under RCM, which were small, diffuse plaques or marginal zones of large plaques, usually showed the membrane-bound form. In the youngest subject with HCHWA-D (47Y), the majority of the diffuse plaques, which was MBC40-negative, exclusively showed membrane-bound forms (Fig. 2e) .
We found no focal plasma membrane labeling outside of the plaque area (Fig. 3d) . Background labeling was minimal and appeared as a single gold particle (Fig. 3d,  arrowhead) .
Cerebellar Diffuse Plaques in Alzheimer Disease
In 2 AD patients, diffuse plaques in the cerebellar molecular layer showed the same 3 forms of A␤ deposits as those in frontal cortex, and the membrane-bound form was also major (Fig. 5a ). In the cerebellum, the plasma membrane of small cell processes (0.1-0.3-m diameter), which gather to form a cluster, became positive. These small processes seemed to be parallel fibers, which were axons of granular cells (21) . Some areas with relatively intense labeling under RCM showed electron-dense substance between cell processes as the nonfibrillar form (Fig. 5b) . The membrane-bound form (Fig. 5a) showed a lower density of the gold particles than the nonfibrillar form (Fig. 5b) . The latter form was surrounded by obscure plasma membrane (Fig. 5b) . We also found fibrillar amyloid in areas with intense labeling under RCM as a minor form.
DISCUSSION
Diffuse plaques (22) , synonymous to preamyloid deposits (23), were defined as Bodian-negative plaques, or A␤ deposits without neuritic alterations, and were referred to as ''diffuse form without nuclear-like central mass'' by Uyematsu (24) and ''diffuse Infiltration des nervösen Gewebes durch die fädigen Massen'' by Fischer (25) . In previous routine EM studies with the guide of A␤ immunostaining of adjacent semithin sections, some areas of diffuse plaques had amyloid fibrils, but most of plaque areas, which were positive at light microscopic level, were free of amyloid fibrils and lacked pathological findings (16, 26, 27) . This finding was confirmed by postembedding immunogold method, where gold labeling was limited to amyloid fibrils between cell processes (28) . In an immuno-EM study with pre-embedding method, however, nonfibrillar materials, i.e. preamyloid, were predominantly found in diffuse plaques (29) . In our previous immuno-EM study on diffuse plaques using Vibratome sections, we found A␤ immunoreactivity on a part of the cell surface plasma membrane together with fibrillar and nonfibrillar forms, although the ultrastructure was poorly preserved (30) . In the current study, the nonfibrillar form was minor and the membrane-bound form was predominant in the weakly labeled area, whereas the fibrillar form was predominant in the intensely labeled area. We used osmium-fixed and epoxy resin-embedded EM materials, which resulted in a high resolution of the ultrastructure. Combination of the well-preserved EM materials, highly specific antibody MBC42, and RCM allowed us to detect the membrane-bound A␤ as the major form. Our previous works without on-grid labeling (16, 26) could not find this form, because the area with membrane-bound A␤ showed no apparent morphological changes, and can be detected only when decollated with gold particles. We clearly demonstrated that A␤ exist as membrane-bound, amorphous, and fibrillar forms, depending on their stages, and thus concluded the argument whether ''preamyloid'' is fibrillar or amorphous (28, 31). We could not determine N-terminal of A␤, because Nterminal directed antibodies did not work well on plastic sections.
A␤42 deposition on the cell surface plasma membrane is a novel finding. Although origin of cell process was frequently unknown, we could identify neuronal processes (parallel fibers) in cerebellum. Accumulation of amyloid protein on cell surface plasma membrane was also reported in murine scrapie model (32) . Immunogold EM studies demonstrated accumulation of prion protein on neuronal plasma membrane without morphological changes. In general, amyloid starts to deposit in basement membrane: vascular basement membrane in HCHWA-D (33), AD (34), secondary amyloidosis (35) and experimental splenic amyloidosis (36) , and basement membrane of Schwann cell in familial amyloid polyneuropathy (37) . In brain parenchyma, however, neuronal plasma membrane can be a site of initial deposition of A␤ and prion protein.
The RCM, which looks like an epi-illumination type fluorescent microscope, is a useful tool in the field of immuno-EM study (33, 38, 39) . It radiates light downward to the surface of the section through a polarizing filter and detects light reflecting from the surface through the polarizing filter again. The positive area of immunogold labeling with silver enhancement shows bright reflecting light that results in a high contrast and a high sensitivity of immuno-detection. We tried formic acid pretreatment for A␤ labeling on RCM sections, but the density of senile plaques was not changed, possibly because labeling for RCM occurs just on the surface of ← showing quite low background labeling. This area has only 1 gold particle (arrowhead) in the neuronal cytoplasm (lower half). Stars indicate the same structure in (b). e: Area with apparent amyloid fibrils in another diffuse plaque. f: Area with gold labeling on axon terminal (arrowheads). Synaptic cleft (c and f, arrow) was negative. c-f: MBC42, 10-nm gold, ϫ26,000. Fig. 4 . Ultrastructure of frontal diffuse plaques in nondemented subjects; MBC42, 10-nm gold, ϫ27,000. a: A␤42 deposition on the cell surface plasma membrane in a weakly labeled part of a diffuse plaque. The synaptic cleft (arrow) was consistently negative. b: Somewhat fibrillar structure was labeled with gold in a part of the diffuse plaque.
tissue section and etching is enough. Formic acid makes EM sections too fragile to observe under EM. Thus, RCM enabled us to detect and evaluate A␤ deposits in ultrathin sections without formic acid pretreatment. Each lesion showed quite similar morphology in adjacent EM-RCM sections and could thus be distinguished from nonspecific binding in the EM sections. For example, even punctate areas of membrane labeling in EM sections were detected as small positive areas in adjacent RCM sections on glass slides due to the 100-nm distance between EM and RCM sections. RCM is a useful tool for the immunogold study.
In the current EM observation of diffuse plaques, the membrane-bound form of A␤ was predominant and consistently found in all diffuse plaques, whereas the fibrillar form appeared only in the areas with intense labeling under RCM. The youngest HCHWA-D subjects showed the membrane-bound form exclusively. The fibrillar form showed a higher density of the gold particles than the membrane-bound form. The plasma membrane tended to be obscured in areas where both fibrillar and nonfibrillar forms were present. From these findings, we concluded that A␤42 deposition begins on a part of the cell surface plasma membrane (possibly outside) in contact with cell processes and continues to increase, forming an amorphous/fibrillar substance between cell processes. The cell surface plasma membrane gradually disappears, and the substance becomes definitely fibrillar with or without codeposition of A␤40. Similar progression of amyloid deposition was reported in murine scrapie model, where prion protein first accumulated on neuronal plasma membrane, and then throughout the adjacent neuropil in association with the extracellular space (32) . In the area with membrane-bound form, gold particles appeared on both sides of the plasma membrane. The indirect immunogold method has discrepancies of up to 20 nm between the real site of the antigen and that of the gold particle, because the molecular size of the primary and secondary The amounts of A␤ (number of gold particles) have increased to form both fibrillar and nonfibrillar materials between small neurites, and the plasma membrane became obscure.
antibodies and also of the gold particles is about 10 nm. This may explain the appearance of gold particles inside the plasma membrane, even when A␤ exists outside of the plasma membrane.
A␤ is produced intra-cellularly in endoplasmic reticulum/Golgi compartments by normal A␤PP metabolism (40) (41) (42) (43) . The threshold of immuno-detection in this study was much higher than the level of normally produced A␤, because the tissues were fixed with formaldehyde, glutaraldehyde, and osmium, and then embedded in epoxy resin. Thus, we detected only an abnormal level of A␤ accumulation, that is, the A␤ deposition on and between plasma membrane. Recently, intraneuronal accumulation of A␤ was reported as an initial deposition (44, 45) , although current study did not show such neuronal labeling. Relation between membrane bound A␤ and intraneuronal A␤ remains to be dissolved.
Biochemical analysis of A␤ deposition in brains exclusively showing diffuse plaques demonstrated that GM1 ganglioside-bound A␤ was a major form (46) . Because GM1 ganglioside localizes on plasma membrane, A␤ may exists in GM1 ganglioside-rich domains of the cell surface plasma membrane (46) . Furthermore, addition of GM1 ganglioside into A␤ solution markedly enhances A␤ fibril formation in vitro (47) . These findings suggest that GM1 ganglioside bound-A␤ on plasma membrane can be an initial species of A␤ deposition, and that GM1 is 1 of the candidates of membrane components that associates with a membrane-bound A␤ found in the current study. There are 2 possibilities with regard to the origin of plasma membrane-bound A␤: the plasma membrane incorporates A␤ from the extra-cellular space (48), or intra-cellular A␤ is transported to the plasma membrane (40) (41) (42) (43) . Detergent-insoluble glycolipid-enriched membrane domains (DIG), rafts or caveolae, are suggested to be carriers of A␤ from the production sites, i.e. endoplasmic reticulum/Golgi, to the cell surface plasma membrane (49) . Caveolae are of interest because normal (50) . Such cholesterol-rich membrane domains are reported to be sites of insoluble A␤ production (51, 52) . It is necessary to clarify which kind of membrane domain is the site of initial A␤ deposition on the plasma membrane.
From the observations of diffuse plaques in relatively young HCHWA-D and nondemented subjects, we conclude that membrane-bound A␤ is an initial form of A␤ deposition. In the case of cerebral amyloid angiopathy, we found small amounts of amorphous materials (33) and amyloid fibrils (34) inside of the basement membrane as initial deposition. However, we found that deposition of apolipoprotein E, vitronectin, and apolipoprotein J precedes A␤ deposition in the vessel wall (53, 54) . It is important to investigate such changes of the plasma membrane, which promote A␤ deposition, to clarify the mechanism of A␤ deposition in senile plaques.
